Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway

Clinical and Experimental Metastasis

Volumn 31, Issue 8, 2014, Pages 961-975

  Epstein Shochet, Gali ^a,b   Tartakover Matalon, Shelly ^a,b   Drucker, Liat ^a,b   Pasmanik Chor, Metsada ^b   Pomeranz, Meir ^a,b   Fishman, Ami ^a,b   Lishner, Michael ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer; EMT; Migration; Placenta; Pregnancy

Indexed keywords

ESTRADIOL; FIBRONECTIN; OSTEOGENIC PROTEIN 1; PROGESTERONE; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INTERACTION; CELL MIGRATION; CELL SURVIVAL; CELLS; COCULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; EXPLANT; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; METASTASIS; PHENOTYPE; PLACENTA; SIGNAL TRANSDUCTION; SUPERNATANT; APOPTOSIS; BREAST TUMOR; CELL COMMUNICATION; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; GENETICS; METABOLISM; PATHOLOGY; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL COMMUNICATION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84916896382     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-014-9683-0     Document Type: Article

References (45)

1. Stensheim H, Moller B, Van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51
2. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689
3. Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287
4. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166(3):781–787
5. Gasim T, Al Dakhiel SA, Al Ghamdi AA, Al Ali M, Al Jama F, Rahman J, Al Suleiman SA, Rahman MS (2010) Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital. Arch Gynecol Obstet 282(5):529–533
6. Ulery M, Carter L, Mcfarlin BL, Giurgescu C (2009) Pregnancy-associated breast cancer: significance of early detection. J Midwife Womens Health 54(5):357–363
7. Amant F, Von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Muller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539
8. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A (2010) Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 16(1):76–82
9. Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 21(4):550–555
10. Baulies S, Cusido M, Tresserra F, Rodriguez I, Ubeda B, Ara C, Fabregas R (2014) Pregnancy-Associated Breast Cancer: an analytical observational study. Med Clin (Barc) 142(5):200–204
11. Madaras L, Kovacs KA, Szasz AM, Kenessey I, Tokes AM, Szekely B, Baranyak Z, Kiss O, Dank M, Kulka J (2013) Clinicopathological features and prognosis of pregnancy associated breast cancer—a matched case control study. Pathol Oncol Res 20:581–590
12. Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872
13. Ali SA, Gupta S, Sehgal R, Vogel V (2012) Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J 18(2):139–144
14. Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A (2013) Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study. Breast Care (Basel) 8(3):203–207
15. Shousha S (2000) Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 124(7):1053–1060
16. Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA (2012) Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol 19(4):1167–1173
17. Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51(1):55–67
18. Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, Feng J, Yang D, Fu L, Yan X (2012) CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 109(4):1127–1132
19. Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I (2006) MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. Mol Cancer 5:57
20. Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98 (discussion 99)
21. Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P (2012) Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer 130(4):910–920
22. Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, Sartorius CA, Tan AC, Heikkila P, Perou CM, Horwitz KB (2012) Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. Proc Natl Acad Sci USA 109(8):2742–2747
23. Tartakover-Matalon S, Mizrahi A, Epstein G, Shneifi A, Drucker L, Pomeranz M, Fishman A, Radnay J, Lishner M (2010) Breast cancer characteristics are modified by first trimester human placenta: in vitro co-culture study. Hum Reprod 25(10):2441–2454
24. Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84(11):985–1000
25. Genbacev Olga, Schubach Stephanie A, Miller Richard K (1992) Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 13(5):439–461
26. Genbacev O, Jensen KD, Powlin SS, Miller RK (1993) In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 14(4):463–475
27. Shochet Epstein (2012) G., S. Tartakover Matalon, L. Drucker, M. Pomeranz, A. Fishman, G. Rashid, V. Oron-Karni, M. Pasmanik-Chor, and M. Lishner, Hormone-dependent placental manipulation of breast cancer cell migration. Hum Reprod 27(1):73–88
28. Chu Y-W, Wang R, Schmid I, Sakamoto M (1999) Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 36(4):333–339
29. Keller A, Backes C, Al-Awadhi M, Gerasch A, Kuntzer J, Kohlbacher O, Kaufmann M, Lenhof HP (2008) GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics 9:552
30. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10:48
31. Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100(11):2218–2225
32. Drabsch Y, Ten Dijke P (2011) TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplas 16(2):97–108
33. Al Saleh S, Al Mulla F, Luqmani YA (2011) Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE 6(6):e20610
34. Band AM, Laiho M (2011) Crosstalk of TGF-beta and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neopl 16(2):109–115
35. Pereg D, Koren G, Lishner M (2008) Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 34(4):302–312
36. Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, Holzgreve W (2003) Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 268(2):69–77
37. Mitchell MJ, King MR (2013) Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 3:44
38. Liu Q, Zhang Y, Mao H, Chen W, Luo N, Zhou Q, Yu X (2012) A crosstalk between the Smad and JNK signaling in the TGF-beta-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. PLoS ONE 7(2):e32009
39. Velden JL, Alcorn JF, Guala AS, Badura EC, Janssen-Heininger YM (2011) c-Jun N-terminal kinase 1 promotes transforming growth factor-beta1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol 44(4):571–581
40. Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16(5):558–564
41. Kalkhoven E, Roelen BA, De Winter JP, Mummery CL, Van Den Eijnden-Van Raaij AJ, Van Der Saag PT, Van Der Burg B (1995) Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6(9):1151–1161
42. Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PH (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 69(23):8853–8861
43. Coradini D, Fornili M, Ambrogi F, Boracchi P, Biganzoli E (2012) TP53 mutation, epithelial–mesenchymal transition, and stemlike features in breast cancer subtypes. J Biomed Biotechnol 2012:254085
44. Lim LY, Vidnovic N, Ellisen LW, Leong CO (2009) Mutant p53 mediates survival of breast cancer cells. Br J Cancer 101(9):1606–1612
45. Manaster I, Goldman-Wohl D, Greenfield C, Nachmani D, Tsukerman P, Hamani Y, Yagel S, Mandelboim O (2012) MiRNA-mediated control of HLA-G expression and function. PLoS ONE 7(3):e33395